The UK buyout firm has submitted a non-binding expression of interest to acquire Frankfurt-listed Synlab at €10 a share, according to a
Synlab said it was examining the proposal and that there’s no certainty Cinven, which already owns 43% of the company, would proceed with an acquisition. Shares in Synlab rose ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.